Candel Therapeutics Inc. (NASDAQ: CADL)
$7.12
+0.5000 ( +7.55% ) 479.8K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$7.12
Previous close
$6.62
Volume
479.8K
Market cap
$212.16M
Day range
$6.47 - $7.30
52 week range
$0.66 - $14.30
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| def | Proxies and info statements | 3 | May 30, 2024 |
| 8-k | 8K-related | 12 | May 30, 2024 |
| ars | Annual reports | 1 | May 30, 2024 |
| 8-k | 8K-related | 14 | May 23, 2024 |
| 10-q | Quarterly Reports | 76 | May 14, 2024 |
| 8-k | 8K-related | 15 | May 14, 2024 |